Medvarsity Logo
Diabetes Innovations in- Glucose Monitoring

CASE DISCUSSION

Diabetes Innovations in- Glucose Monitoring

India flagPresented India by Dr. J. Jayaprakashsai

Views

7,821

Case Description

Continuous Glucose Monitoring (CGM) devices have revolutionized diabetes management by providing real-time glucose readings, eliminating the need for finger-pricking. Advances in CGM technology have led to smaller, more discreet sensors that can be worn for longer periods, improving patient...

Case Summary

  • Blood glucose monitoring is essential in managing diabetes, and continuous glucose monitoring (CGM) is a significant advancement, offering insights beyond HbA1c, which reflects long-term glycemia. CGM helps understand daily glucose fluctuations, crucial for personalized management and reducing complications. Time in range (TIR) is a vital metric, as suboptimal TIR can lead to micro and macrovascular complications, impacting the quality of life for diabetic patients.

Speaker Profile

Dr. J. Jayaprakashsai

Dr. J. Jayaprakashsai

Senior General Physician, Diabetologist, Apollo Sugar Clinics, Hyderabad
Dr. J. Jayaprakashsai is a Senior General Physician and Diabetologist associated with Apollo Sugar Clinics. He has extensive experience in the management of diabetes, metabolic disorders, hypertension, and lifestyle-related diseases. His clinical approach focuses on preventive healthcare, patient education, and personalized diabetes management strategies. He is dedicated to delivering evidence-based care aimed at improving long-term health outcomes and quality of life for patients. Through his clinical practice, he continues to contribute to advancing diabetes care and preventive medicine.

Disclosures

Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Diabetes Innovations in- Glucose Monitoring